History
  • No items yet
midpage
Xerox Corporation v. United States
21-1807
Fed. Cl.
Sep 17, 2021
Read the full case

Background

  • DLA issued Solicitation SP7000-19-R-1001 (2019) for a single contract to supply copiers, support, and supplies for use aboard military ships.
  • After technical evaluations and a reverse auction, DLA awarded the contract to Trident E&P, Inc. on August 20, 2021; Xerox (incumbent) unsuccessfully protested at GAO and filed suit in the Court of Federal Claims.
  • DLA is in a transition/testing period (≈180 days) during which it is prohibited from placing orders with Trident; Xerox has performed under successive bridge contracts and alleges DLA declined to obligate funds for a new bridge.
  • Xerox seeks a TRO/preliminary injunction to stop Trident’s testing, prevent orders under the award, and to prohibit DLA from impairing Xerox’s ability to serve existing customers.
  • Xerox’s substantive challenges: (1) Trident’s proposal was technically unacceptable for failing to meet material requirements; (2) the reverse-auction lacked transparency, causing Xerox to submit a higher price.
  • The Court applied the Winter four-factor injunction test, focused on irreparable harm, and declined to reach a definitive merits ruling.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether Xerox demonstrated irreparable harm to obtain a TRO/PI Lost profits from potential orders to Trident; inability to serve customers without a new bridge; loss of competitive advantage from Trident testing No orders can be placed during 180-day testing; agency is seeking bridge authority; alleged harms are speculative Denied—Xerox failed to show irreparable harm, so injunction not warranted
Whether the Court should compel DLA to execute a new bridge contract or obligate funds Requests order prohibiting DLA from impairing Xerox’s ability to serve customers (effectively compel a bridge) Execution/obligation of bridge contracts is an agency discretion and DLA is already pursuing authority for a bridge Denied—court will not order the agency to execute or obligate a bridge contract; left to agency discretion
Whether testing of Trident’s equipment causes cognizable competitive harm affecting the procurement Testing will erode Xerox’s advantage because Xerox’s equipment is preapproved Testing is post-award, had no bearing on proposal evaluation; Trident qualified without preapproval; any future competitive harm is speculative Denied as basis for injunctive relief—testing does not establish irreparable harm or affect reevaluation
Likelihood of Xerox’s success on the merits of the procurement challenges Trident’s proposal was technically deficient; reverse auction unfairly hidden competitors Award followed reverse-auction rules; GAO denied Xerox’s protest; selection was based on lowest eligible price Court made no definitive finding on entitlement to relief; Xerox did not show likelihood of success sufficiently to overcome lack of irreparable harm

Key Cases Cited

  • Winter v. Natural Resources Defense Council, 555 U.S. 7 (2008) (standard for preliminary injunction requires showing likely success and irreparable harm)
  • FMC Corp. v. United States, 3 F.3d 424 (1993) (injunction factors and their interplay)
  • Amazon.com, Inc. v. Barnesandnoble.com, Inc., 239 F.3d 1343 (2001) (movant must establish both likelihood of success and irreparable harm)
  • Quality Control Int’l, LLC v. United States, 147 Fed. Cl. 193 (2020) (scope of court authority to compel agency to enter bridge contracts)
  • SVD Stars II, LLC v. United States, 138 Fed. Cl. 483 (2018) (speculative competitive injury insufficient for irreparable harm)
  • Sierra Military Health Servs., Inc. v. United States, 58 Fed. Cl. 573 (2003) (post-award events and speculative harm do not establish irreparable injury)
  • Bannum, Inc. v. United States, 121 Fed. Cl. 543 (2015) (procedural context for bridge contracts and agency discretion)
Read the full case

Case Details

Case Name: Xerox Corporation v. United States
Court Name: United States Court of Federal Claims
Date Published: Sep 17, 2021
Citation: 21-1807
Docket Number: 21-1807
Court Abbreviation: Fed. Cl.